Transcode Therapeutics Inc.

18/12/2024 | Press release | Distributed by Public on 18/12/2024 13:01

TransCode Therapeutics Announces Safety Review Committee Approval of Opening Third Cohort and Preliminary Results from First Cohort in Phase 1 TTX-MC138 Clinical Trial

Read this content
Click here to read the original version at the source's official website. The text of this article is not available at the moment.